Back to User profile » Dr Shun Lu
Papers published by Dr Shun Lu:
Response and acquired resistance to savolitinib in a patient with pulmonary sarcomatoid carcinoma harboring MET exon 14 skipping mutation: a case report
Han S, Fang J, Lu S, Wang L, Li J, Cheng M, Ren Y, Su W
OncoTargets and Therapy 2019, 12:7323-7328
Published Date: 6 September 2019
Development of treatment options for Chinese patients with advanced squamous cell lung cancer: focus on afatinib
Lu S
OncoTargets and Therapy 2019, 12:1521-1538
Published Date: 22 February 2019
Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-Lung 6 trial
Wu YL, Xu CR, Hu CP, Feng J, Lu S, Huang Y, Li W, Hou M, Shi JH, Märten A, Fan J, Peil B, Zhou C
OncoTargets and Therapy 2018, 11:8575-8587
Published Date: 30 November 2018
Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung
Lu S, Li W, Zhou C, Hu CP, Qin S, Cheng G, Feng J, Wang J, Cseh A, Peil B, Gibson N, Ehrnrooth E, Zhang L
OncoTargets and Therapy 2018, 11:8565-8573
Published Date: 30 November 2018
A novel paclitaxel-loaded poly(D,L-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment
Yuan X, Ji W, Chen S, Bao Y, Tan S, Lu S, Wu K, Chu Q
International Journal of Nanomedicine 2016, 11:2119-2131
Published Date: 25 May 2016